3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Glioblastoma
7
Urinary Bladder Neoplasms
6
Breast Neoplasms
6
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Carcinoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Sarcoma
4
Squamous Cell Carcinoma of Head and Neck
3
Rhabdomyosarcoma, Embryonal
3
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Adenocarcinoma of Lung
3
Triple Negative Breast Neoplasms
2
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Rhabdomyosarcoma, Alveolar
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Prostate Adenocarcinoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Melanoma
2
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Radiation
×
30 days
×
Clear all
No trials found.